Programme
Programme – Final (latest update March 15, 2026)
Wednesday, April 8, 2026
Wellcome reception, Copenhagen City Hall
(Special registration required)
Thursday, April 9, 2026
Session 1: Molecular brain tumor classification and concepts in tumor biology
Session 2: Microenvironment
Session 3: Immunotherapy and trial updates
Session 4: Meningiomas
Session 5: Neurosurgery
Conference dinner and boat trip, Langelinje Pavillon, Copenhagen habour (Special registration required)
Friday, April 10, 2026
Session 6: Clinical trials – and radiation therapy
Session 7: Symptom management and quality of life
Session 8: Neuroimaging and theranostics
Session 9: AI and novel therapeutic approaches
Programme
Wednesday, April 8, 2026
Programme – Final (Last updated: April 1, 2026)
19:30
Welcome Reception
Copenhagen City Hall
Rådhuspladsen 1, 1553 Copenhagen
Come and meet your fellow participants at the Welcome Reception at the beautiful Copenhagen City Hall and enjoy the famous city hall pancakes. Participation is included in the registration fee.
Participation is limited to pre-registered participants.
Programme
Thursday, April 9, 2026
Programme – Final (Last updated: April 6, 2026)
8:30
Welcome
Bjarne Winther Kristensen – Copenhagen, Denmark
8:40
Session 1
Molecular brain tumor classification and concepts in tumor biology
Chairs:
Bjarne Winther Kristensen & Joachim Weischenfeldt
8:40
Felix Sahm – Heidelberg, Germany
Next level diagnostics
9:10
Olivera Casar-Borota – Uppsala, Sweden
Towards a molecular classification of PitNETs
9:25
Mario Suva – Boston, USA
Single-cell and spatial transcriptomic analysis of human gliomas
9:55
David Scheie – Copenhagen, Denmark
How nanopore sequencing has revolutionized CNS tumors diagnostics
10:10
Presentation based on selected abstract
Josephine Heinold
Resolving the regulation of glioblastoma cell states by CRISPR-TAG reverse genetics
10:20
Coffee / Exhibition / Posters
10:35
Session 2
Microenvironment
Chairs:
Kirsi Rautajoki & Lisa Myllykangas
10:35
Leila Akkari – Amsterdam, The Netherlands
Unveiling macrophage diversity in the brain cancer ecosystem: A matter of plasticity and metabolism
11:05
Presentation based on selected abstract
Mathilde Søbye Blaavand
ROCK1 and periostin mediate invasion in NF1-deficient glioblastoma
11:12
Marco Prinz – Freiburg, Germany
The myeloid side of the brain
11:45
Lunch
Please collect your finger-food lunch and bring it into the conference room for the Lunch Symposium
12:00
Lunch symposium
Redefining low-grade glioma management in the era of molecular oncology Access the detailed programme here
13:00
Coffee / Exhibition / Posters
13:30
Session 3
Immunotherapy and trial updates
Chairs:
Thomas Haargaard Urup & Ulrik Lassen
13:30
Michael Platten – Heidelberg, Germany
Targeting T cells to clonal driver mutations in glioma
13:50 – Canceled
Christel Herold-Mende – Heidelberg, Germany
Dissecting the cellular architecture of breast cancer brain metastases reveals prognostically distinct immune landscapes
Please note that from this point the programme has been updated due to a cancellation (April 6, 2026)
14:00
Presentation based on selected abstract
Anuja Lipsa
Functional precision medicine screening reveals personalized therapeutic vulnerabilities in adult high-grade glioma subtypes
14:07
Session 4
Meningiomas
Chairs: Asgeir Jakola & Karen Bonde Larsen
14:07
Tiit Illimar Mathiesen – Copenhagen, Denmark
Three pitfalls in meningioma management
14:22
Anders Korshøj – Aarhus, Denmark
Nationwide population-based trends in incidence, care, and imaging surveillance of meningioma: Results from 8,134 Danish patients (2010-2023)
14:37
Mikkel Schou Andersen – Odense, Denmark
Modelling the meningioma – insights from in vivo and in vitro approaches
14:52
Presentation based on selected abstract
Jasim Kada Benotmane
Functional multiomics of brain-invasive meningioma reveals ecosystems of macrophage interaction and neuron-tumor networks
15:00
Coffee / Exhibition / Posters
Poster session
16:00
Session 5
Neurosurgery
Chairs:
Jane Skjøth-Rasmussen & Frantz R. Poulsen
16:00
Philipp Karschnia – München, Germany
RESECTography: Mapping the oncological benefit of surgery for personalized glioma resections
16:30
Asgeir Jakola – Gothenburg, Sweden
Supramaximal resection in glioblastoma: Current state of the evidence
16:45
Jane Skjøth-Rasmussen – Copenhagen, Denmark
Tumor delineation – an update on fluorescent guided surgery in low grade glioma and meningioma using FG001- a uPAR-targeting fluorescent agent
17:00
Presentation based on selected abstract
Margret Jensdottir
Surgical selection and outcome of insular low grade gliomas – Historical series from a Scandinavian multi-center database
17:10
Thursday’s programme concludes
17:50
Congress dinner – (Special registration required)
We leave the conference center by foot
We walk together to Fisketorvet, Havneholmen, where the boat that will take us to Langelinie Pavillonen is docked.
Canal Tour
The boats leave from Fisketorvet, Havneholmen on time. Please arrive promptly.
Dinner – Langelinie Pavillonen, Langelinie 10, 2100 Copenhagen
Upon arrival at the beautiful Langelinie Pavillonen, a delicious three-course menu awaits you.
Please have your dinner ticket ready and provide it upon arrival at Langelinie Pavillonen. Participation is limited to pre-registered participants.
Programme
Friday, April 10, 2026
Programme – Final (last updated: March 26, 2026)
8:30
Session 6
Clinical trials – and radiation therapy
Chairs:
Benedikte Hasselbalch & Maria Sandström
8:30
Howard Colman – Utah, USA
Eflornithine plus lomustine improves overall survival and progression-free survival compared to lomustine alone in recurrent astrocytoma, IDH-mutant, WHO grade 3: Updated results of the Phase 3 STELLAR trial
9:00
Anna Berghoff – Vienna, Austria
Functional precision medicine: patient derived cell based drug screening in glioblastoma
9:30
Kirsi Rautajoki – Tampere, Finland
Progression of IDH-mutant astrocytomas after therapy
9:45
Presentation based on selected abstract
Levi van Hijfte
Infiltrative tumour cell populations adopt conserved transcriptional programs in IDHmt diffuse adult glioma
9:52
Vincent Fougner – Copenhagen, Denmark
GBM trial design: Lessons learned and new strategies
10:07
Petter Brandal – Oslo, Norway
Proton therapy in brain tumors – will we ever know if the promise is fulfilled?
10:22
Presentation based on selected abstract
Pauline Jeannot
Targeting of astrocyte reactivity in glioblastoma to prevent radioresistance
10:30
Coffee / Exhibition / Posters
Poster session
11:30
Session 7
Symptom management and quality of life
Chairs:
Helle Sørensen von Essen & Isabelle Rydén
11:30
Florien Boele – Leeds, United Kingdom
Quality of life and neurocognitive functioning in brain tumor survivorship
12:00
Karin Piil – Copenhagen, Denmark
Understanding the patient needs to build personalized pathways
12:15
Anneli Ozanne – Gothenburg, Sweden
Supportive strategies for patients and families along the brain tumor care pathway
12:30
Presentation based on selected abstract
Lena Rosenlund
Ten years with patient-reported measures in the Swedish national quality registry for brain tumors and now in the Individual Patient Overview
12:40
Lunch / Exhibition / Posters
13:25
Session 8
Neuroimaging and theranostics
Chairs:
Adam Espe Hansen & Ingerid Reinertsen
13:25
Atle Bjørnerud – Oslo, Norway
Applications of artificial intelligence in neuro-oncology imaging
13:40
Live Eikenes – Trondheim, Norway
68Ga/177Lu-PSMA theranostic in recurrent high-grade glioma
13:55
David Bouget – Trondheim, Norway
From pixels to protocols: advancing neurosurgical decision support with AI-based segmentation and reporting
14:10
Presentation based on selected abstract
Sebastian Jeising
Multimodal imaging-guided tissue sampling combined with multiomics profiling informs on spatial molecular and cellular heterogeneity linked to distinct imaging features in diffuse gliomas
14:17
Presentation based on selected abstract
Claes Johnstad
Population-based validation of the RANO categories for extent of resection in glioblastoma
14:25
Coffee / Exhibition / Posters
14:45
Session 9
AI and novel therapeutic approaches
Chairs:
Petter Brandal & Titt Illimar Mathiesen
14:45
Dieter Henrik Heiland – Freiburg, Germany
Molecular guided neurosurgery – from exploration to application
15:15
Austin Evans – Tampere, Finland
Multifunctional heparin nanoparticles for therapeutic reprogramming of glioblastoma and beyond
15:30
Anders Korshøj – Aarhus, Denmark
Window-of-opportunity trials in newly diagnosed GBM – challenges and perspectives
15:45
Presentation based on selected abstract
Atul Anand
IBSP⁺ myeloid cells drive hypoxia-induced stress tolerance and malignant progression in glioblastoma
15:52
Presentation based on selected abstract
Lars Karlsson
CAR T-induced vascular alterations in diffuse intrinsic pontine glioma (DIPG)
16:00
Prizes
Bjarne Winther Kristensen – Copenhagen, Denmark
Prizes will be awarded for:
- Best Basic Research Poster
- Best Clinical Research Poster
- Best Talk
Sponsored by Marginum & Elekta solutions
16:10
Goodbye and thank you
Bjarne Winther Kristensen – Copenhagen, Denmark